Parallax Volatility Advisers, L.P. Myriad Genetics Inc Transaction History

Parallax Volatility Advisers, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$24.13 - $32.63 $405,697 - $548,608	-16,813 Reduced 67.74%	8,008 $221,000
Q2 2019 Aug 14, 2019	SELL	$22.67 - $35.0 $3.27 Million - $5.05 Million	-144,270 Reduced 85.32%	24,821 $690,000
Q1 2019 May 15, 2019	BUY	$26.93 - $34.7 $4.55 Million - $5.87 Million	169,091 New	169,091 $5.61 Million
Q3 2018 Nov 14, 2018	SELL	$37.57 - $50.34 $4,470 - $5,990	-119 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$28.83 - $41.01 $279,910 - $398,166	-9,709 Reduced 98.79%	119 $4,000
Q4 2017 Feb 14, 2018	BUY	$28.45 - $37.14 $279,606 - $365,011	9,828	9,828 $338,000

253

90.5M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.11B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.